Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Most Accessed Articles
CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
, 2020; 20(2): 156-165.Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220
Immune Checkpoint Inhibitors in AML-A New Frontier
, 2020; 20(7): 545-557.Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*
DOI: 10.2174/1568009620666200421081455
Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review
, 2020; 20(9): 720-727.Jianguo Qiu, Wei Tang and Chengyou Du*
DOI: 10.2174/1568009620666200520084415
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide
, 2020; 20(6): 410-416.Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
, 2020; 20(11): 887-895.Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI: 10.2174/1568009620999200918122426
VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways
, 2020; 20(8): 616-623.Jing-Yi Sun, Ya-Jun Hou, Hai-Juan Cui, Cheng Zhang, Ming-Feng Yang, Feng-Ze Wang, Zheng Sun, Cun-Dong Fan*, Bao-Liang Sun* and Jin Rok Oh*
DOI: 10.2174/1568009620666200414150353
Exosome as a Natural Gene Delivery Vector for Cancer Treatment
, 2020; 20(11): 821-830.Prasad Pofali, Adrita Mondal and Vaishali Londhe*
DOI: 10.2174/1568009620666200924154149
Strategic Combination Therapies for Ovarian Cancer
, 2020; 20(8): 573-585.Xinran Li, Angel S.N. Ng, Victor C.Y. Mak, Karen K.L. Chan, Annie N.Y. Cheung and Lydia W.T. Cheung*
DOI: 10.2174/1568009620666200511084007
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
, 2020; 20(8): 586-602.Manzoor A. Mir*, Hina Qayoom, Umar Mehraj, Safura Nisar, Basharat Bhat and Nissar A. Wani*
DOI: 10.2174/1570163817666200518081955
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation
, 2020; 20(7): 490-500.Justin S. Becker and Amir T. Fathi*
DOI: 10.2174/1568009620666200424145622
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma
, 2020; 20(11): 875-886.Yingyi Wang, Bao Jin, Na Zhou, Zhao Sun, Jiayi Li, Qiao Chen, Xiangan Wu, Yi Zhou, Yue Shi, Xin Lu, Xinting Sang, Yilei Mao, Shunda Du*, Wenze Wang* and Chunmei Bai*
DOI: 10.2174/1568009620999200918121456
Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy
, 2020; 20(11): 853-867.Han Gong, Dan Nie and Zhengyu Li*
DOI: 10.2174/1568009620999200816130218
The Evolving AML Genomic Landscape: Therapeutic Implications
, 2020; 20(7): 532-544.Sachi Horibata*, George Alyateem, Christin B. DeStefano and Michael M. Gottesman*
DOI: 10.2174/1568009620666200424150321
Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
, 2020; 20(8): 559-572.Mamta Kumari, Praveen Thaggikuppe Krishnamurthy* and Piyong Sola
DOI: 10.2174/1568009620666200506110850
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors
, 2021; 21(1): 2-20.Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005
Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients
, 2020; 20(8): 638-645.Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Sherief Abd-Elsalam* and Marwa A. Suliman
DOI: 10.2174/1568009620666200511084731
Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer
, 2020; 20(8): 603-615.Ali Sartaj, Sanjula Baboota and Javed Ali*
DOI: 10.2174/1568009620666200331124113
FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects
, 2020; 20(7): 513-531.Francesca L. Hogan, Victoria Williams and Steven Knapper*
DOI: 10.2174/1570163817666200518075820
Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway
, 2020; 20(8): 624-637.Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu and Bin Yi*
DOI: 10.2174/1568009620666200424145122
Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
, 2020; 20(7): 473-489.Vaibhav Agrawal*, Olumide B. Gbolahan, Maximilian Stahl, Amer M. Zeidan, Mohammad Abu Zaid, Sherif S. Farag and Heiko Konig*
DOI: 10.2174/1568009620666200502011059
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Webmaster Contact: info@benthamscience.net